Clinical Trials Logo

Filter by:
NCT ID: NCT02047981 Completed - Childhood Mortality Clinical Trials

Mortality Reduction After Oral Azithromycin: Mortality Study

MORDORIMort
Start date: December 2014
Phase: Phase 4
Study type: Interventional

Our long-term goal is to more precisely define the role of mass azithromycin treatments as an intervention for reducing childhood mortality. We propose a single multi-site (multi-country), cluster-randomized trial comparing communities randomized to oral azithromycin with those randomized to placebo. We hypothesize that mass azithromycin treatments will reduce childhood mortality.

NCT ID: NCT02005835 Recruiting - HIV Clinical Trials

Promoting Uptake and Retention of Option B+ in Malawi

PURE
Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if enhanced support for women and their families within facilities and/or through community outreach will result in improved retention in the continuum of PMTCT care.

NCT ID: NCT01991652 Recruiting - Wilms Tumour Clinical Trials

Collaborative Wilms Tumour Africa Project

Start date: January 2014
Phase:
Study type: Observational

Significant progress has been made in the treatment of Wilms tumor in high income countries, where survival is now around 85% - 90%. Survival in low income countries is much lower; specific challenges include late presentation, malnutrition, less intense supportive care facilities and failure to complete treatment. A comprehensive treatment guideline was introduced in Malawi in 2006 which included nutritional support and social support to enable parents to complete treatment. Survival has increased to around 50%; 95% of children completed their treatment. A multi-disciplinary group of African clinicians and 'state of the art' experts produced a consensus treatment guideline for children with Wilms tumor in sub-Saharan Africa. This guideline will be implemented as a multi-center prospective clinical trial in 2014 in six - eight institutes, expecting about 200 new patients per year. The hypothesis is that 2 year event free survival will be 50%, with <10% failure to complete treatment and <10% treatment related mortality. Other research questions include efficacy and toxicity of preoperative chemotherapy and the comparison of surgical staging, local pathology and central review pathology in stratifying postoperative chemotherapy.

NCT ID: NCT01982812 Completed - Epilepsy Clinical Trials

A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM

Start date: January 2014
Phase: Phase 2
Study type: Interventional

Pediatric cerebral malaria (CM) affects more than 3 million children each year killing ~20% and leaving one third of survivors with long term neurologic and psychiatric sequelae. Seizures occur commonly with CM and are associated with an increased risk of death and neuropsychiatric disabilities. In this Malawi-based, dose- escalation, safety and feasibility study of enteral levetiracetam in pediatric CM, the investigators will lay the groundwork for future efficacy studies aimed at improving seizure control and ultimately decreasing the neurologic morbidity of pediatric CM.

NCT ID: NCT01893021 Completed - Contraception Clinical Trials

Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women

Start date: May 2013
Phase: N/A
Study type: Observational

The purpose of this study is to understand the family planning needs and practices of postpartum Malawian women, with a focus on long-acting reversible contraception (LARC). Hypotheses: 1. Postpartum women who are older, who have a history of unintended pregnancy, who do not desire another child within 2 years, and who were counseled about LARC during their pregnancy are more likely to have interest in using LARC. 2. Postpartum women who are older are more likely to be aware of LARC methods. 3. HIV+ postpartum Malawian women will have similar knowledge about LARC as postpartum Malawian women who are HIV-.

NCT ID: NCT01891149 Completed - Obstetric Fistula Clinical Trials

Ultrasonographic and Hormonal Characteristics of Malawian Women With and Without Obstetric Fistula

Start date: December 2012
Phase: N/A
Study type: Observational

This study is a cross-sectional study of 110 Malawian women to compare the ultrasonographic and hormonal characteristics of women and without obstetric fistula. Hypothesis #1: Women with obstetric fistula have a mean cervical length measurement that is at least 10 mm shorter than the mean cervical length measurement of similar women without obstetric fistula. Hypothesis #2: Evaluation of the hormonal and ultrasonographic characteristics of women with obstetric fistula will allow us to assess the cause of amenorrhea in these women.

NCT ID: NCT01873196 Completed - Child Malnutrition Clinical Trials

Food Aid Quality Review: Feasibility and Acceptability Study of Corn Soy Blend and Fortified Vegetable Oil in Malawi

FAQR-Malawi
Start date: July 2013
Phase: N/A
Study type: Interventional

This research will test alternative methods of ensuring compliance with recommended preparation and targeting of supplementary foods for malnourished children under five years of age. The hypotheses that the proposed study intends to test are as follows: 1. With appropriate behavior change communication (BCC) and social support, and with provision of CSB and FVO in the correct proportions, it is possible to get women to prepare CSB with oil in the recommended ratio of 100:30, and in quantities just sufficient for the target child. 2. Providing CSB to Beneficiary Mothers/Caretakers pre-packaged bags of 2 kg with appropriate messaging and with instructions to direct the food to children and to prepare the CSB with oil in the recommended ratio and feed as instructed will result in better compliance.

NCT ID: NCT01825031 Completed - Clinical trials for Human Immunodeficiency Virus

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

REALITY
Start date: June 2013
Phase: Phase 3
Study type: Interventional

A randomised controlled trial to investigate three methods to reduce early mortality in adults, adolescents and children aged 5 years or older starting antiretroviral therapy (ART) with severe immuno-deficiency. The three methods are: (i) increasing the potency of ART with a 12 week induction period using 4 antiretroviral drugs from 3 classes (ii) augmented prophylaxis against opportunistic/bacterial infections and helminths for 12 weeks (iii) macronutrient intervention using ready-to-use supplementary food for 12 weeks.

NCT ID: NCT01818258 Completed - HIV Positive Clinical Trials

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Start date: October 26, 2015
Phase: Phase 4
Study type: Interventional

Children living with HIV from sub-Saharan Africa often present with severe malnutrition. In severe malnutrition, metabolic and/or gut structural derangement may lead to inadequate antiretroviral (ARV) absorption and/or erratic drug levels. The greater surface area to weight ratio in severely malnourished children could also place them at higher risk of under dosing compared to children with mild to moderate malnutrition. However, limited data are available on the pharmacokinetics of ARVs in severely malnourished children. This study addressed this critical gap in knowledge by evaluating the PK of zidovudine (ZDV), lamivudine (3TC), and lopinavir/ritonavir (LPV/r) in severely malnourished children living with HIV, compared to children with normal nutrition to mild malnutrition living with HIV.

NCT ID: NCT01811836 Completed - Enteropathy Clinical Trials

Zinc Resistant Starch Project

Start date: March 2013
Phase: N/A
Study type: Interventional

Broad - to examine the result of feeding RS to 3-5 year old rural Malawian children on zinc homeostasis and environmental enteropathy (EE). Specific - 1. To measure zinc status using a dual zinc stable isotope assay before and after administering resistant starch (RS) in 20 children. 2. To measure intestinal function using a site-specific sugar absorption test before and after administering RS in 20 children. 3. To determine the relationship between RS and zinc homeostasis. 4. To determine the relationship between RS and environmental enteropathy.